Concepedia

Naofumi Yui

NY

14

Publications

714

Citations

13

H-Index

2009

Active since

Affiliations

Tokyo Medical and Dental University(Current)

Harvard University

Massachusetts General Hospital

Tohoku Medical and Pharmaceutical University

Center for Systems Biology

Naofumi Yui is an author at Tokyo Medical and Dental University specializing in medicine, cell signaling, and signal transduction.

ORCID

Top concepts

Publications per year

2009–2022

14

Publications

14

Noncanonical Control of Vasopressin Receptor Type 2 Signaling by Retromer and Arrestin

Timothy N. Feinstein, Naofumi Yui, Matthew J. Webber et al. · Journal of Biological Chemistry · 2013 · 222 citations · Full text

, , +12

Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure

Akihito Ohta, Tatemitsu Rai, Naofumi Yui et al. · Human Molecular Genetics · 2009 · 106 citations · Full text

Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway

Fumiaki Ando, Eisei Sohara, Tetsuji Morimoto et al. · Nature Communications · 2016 · 62 citations · Full text

Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in <scp>J</scp>apan: The <scp>CKD‐ROUTE</scp> study

Soichiro Iimori, Shotaro Naito, Yumi Noda et al. · Nephrology · 2015 · 61 citations

The proteasome inhibitor bortezomib attenuates renal fibrosis in mice via the suppression of TGF-β1

Moko Zeniya, Takayasu Mori, Naofumi Yui et al. · Scientific Reports · 2017 · 43 citations · Full text

Rows per page

1–5 of 14